Standard BioTools Free Cash Flow Per Share 2010-2024 | LAB

Standard BioTools free cash flow per share from 2010 to 2024. Free cash flow per share can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Standard BioTools Free Cash Flow Per Share 2010-2024 | LAB

Standard BioTools free cash flow per share from 2010 to 2024. Free cash flow per share can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$37.2B
Hims & Hers Health (HIMS)$15B
Tempus AI (TEM)$13.5B
Inspire Medical Systems (INSP)$5.3B
IRhythm Technologies (IRTC)$3.5B
Privia Health (PRVA)$3.1B
Enovis (ENOV)$2.5B
Clover Health Investments (CLOV)$2.3B
Azenta (AZTA)$2.1B
Schrodinger (SDGR)$1.9B
Omnicell (OMCL)$1.9B
Phreesia (PHR)$1.7B
10x Genomics (TXG)$1.5B
Butterfly Network (BFLY)$1B
Talkspace (TALK)$652M
Fulgent Genetics (FLGT)$531M
TruBridge (TBRG)$426M
Nyxoah SA (NYXH)$357M
Health Catalyst (HCAT)$338M
SOPHiA GENETICS SA (SOPH)$319M
Pulmonx (LUNG)$262M
American Well (AMWL)$191M
EUDA Health Holdings (EUDA)$102M
MDxHealth SA (MDXH)$88M
P3 Health Partners (PIII)$77M
111 (YI)$69M
CareCloud (CCLD)$63M
HeartBeam (BEAT)$58M
Outset Medical (OM)$50M
Zepp Health (ZEPP)$45M